Skip to main content
. 2021 Dec 10;89(3):251–260. doi: 10.1097/QAI.0000000000002876

TABLE 3.

Predictors of High (5+ Doses/Week) Electronically Monitored PrEP Adherence

  N participant Visits (%) or Mean (SD) Unadjusted Odds Ratio (95% CI) P Adjusted Odds Ratio (95% CI) P
Individual factors
 Baseline VOICE risk score 6 (1) 0.75 (0.62 to 0.92) 0.005 0.73 (0.58 to 0.91) 0.006
 Age at baseline (yr) 21 (2) 0.99 (0.91 to 1.10) 0.95
 Education (yr) 11 (2) 0.92 (0.86 to 0.98) 0.015 0.94 (0.87 to 1.02) 0.12
 Possible depression 6 (13%) 0.64 (0.27,1.50) 0.30
 Low self-esteem 4 (10%) 0.41 (0.06 to 2.6) 0.35
 Problematic alcohol use 20 (14%) 1.04 (0.67 to 1.61) 0.86
 Prior daily medication use 55 (19%) 0.80 (0.49 to 1.32) 0.39
Perceived necessity for PrEP 0.82
 Low (1–1.8) 75 (21%) Ref
 Moderate (1.9–2.1) 156 (22%) 0.98 (0.67 to 1.43)
 High (2.1–4.0) 154 (19%) 0.89 (0.58 to 1.37)
Concerns about taking PrEP 0.30
 Low (2.4–3.5) 110 (20%) Ref
 Moderate (3.6–3.9) 164 (22%) 0.91 (0.67 to 1.25)
 High (4.0–5.0) 111 (18%) 0.73 (0.49 to 1.09)
Risk attitude 0.29
 Low tolerance for risk 133 (21%) Ref
 Moderate tolerance for risk 152 (20%) 1.07 (0.74 to 1.56)
 High tolerance for risk 99 (20%) 1.19 (0.80 to 1.79)
Partnership factors
 Any HIV+ partner 33 (32%) 1.16 (0.64 to 2.13) 0.62
 > 1 current sexual partner 96 (21%) 1.00 (0.99 to 1.01) 0.90 1.82 (1.32 to 2.51) <0.001
 Condomless sex 203 (20%) 1.11 (0.87 to 1.42) 0.39
Sexual relationship power* 0.06 0.06
 Low (1.0–2.4) 41 (14%) Ref
 Moderate (2.5–2.8) 168 (23%) 1.51 (1.06 to 2.14)
 High (2.9–4.0) 159 (21%) 1.23 (0.81 to 1.86)
Intimate partner violence 5 (16%) 1.04 (0.46 to 2.36) 0.92
Community factors
 PrEP disclosure 300 (21%) 1.25 (0.92 to 1.71) 0.16 1.07 (0.74 to 1.54) 0.73
Perceived HIV stigma
 Low (4–11) 189 (21%) 1.41 (0.99 to 2.00) Ref 0.06 1.45 (1.00 to 2.09) Ref 0.05
 High (12–16) 196 (20%)
Structural factors
 Site: Thika
  Kisumu
129 (16%)
256 (23%)
Ref
1.37 (1.10 to 1.56)

0.01
Ref
1.57 (1.02 to 2.43)

0.04
 Travel ≤1 hour to study 199 (21%) 1.41 (1.09 to 1.82) 0.008 1.39 (1.05 to 1.84) 0.02

N refers to the number of participant visits with each factor at which the average adherence was 5+ doses/week; the mean references those participants with 5+ doses/week at 1 or more of the participant visits. All measures were updated over time unless noted as baseline values. Bold indicates significance (P < 0.05) in the multivariable model.

*

Among those with a primary sexual relationship.